Industry News

Colleen Lance react health
Industry News

Colleen Lance, MD Joins React Health as CMO

React Health is pleased to announce the appointment of Dr. Colleen G. Lance as its Chief Medical Officer. Dr. Lance is joining React Health as part of its executive leadership team effective November 2, 2023. She most recently was a staff physician at the Cleveland Clinic, serving as Medical Director […]

nox health
Industry News

Nox Health: New Directors Bring Significant Experience Across Health Systems, Employer benefits and Care Delivery

Nox Health, a global sleep health leader in sleep diagnostics and value-based sleep care management, today announced the appointment of three new board members: Lloyd Dean, Chief Executive Emeritus, CommonSpirit Health; David Schlanger, Executive Chairman, Progyny; Dr. Bill Lewis, Telehealth Consultant to Fortune 500 companies. “Sleep is the missing gap […]

Brigitte Nettesheim president nox health
Industry News

Nox Health Names Brigitte Nettesheim as President, Enterprise

Nox Health, a global leader in sleep diagnostics and value-based sleep care management, today announced that Brigitte Nettesheim has been appointed President, Nox Health, Enterprise business, effective immediately. In this role, Brigitte will have responsibility for Nox Health’s value-based sleep care management business, which provides plan sponsors and health plans […]

Noctrix Health TOMAC RLS Therapy Studies
Industry News Restless Leg Syndrome

Landmark Results from Two Noctrix Health TOMAC RLS Therapy Studies

Noctrix Health, Inc. announced a double feature in the renowned peer-reviewed journal, Sleep, showcasing the outcomes of two major clinical trials that assessed TOMAC therapy for the treatment of restless legs syndrome (RLS). The two papers feature the results from the RESTFUL study (NCT04874155), a multi-center, randomized, sham-controlled clinical trial, and a subsequent […]

Dental Sleep Medicine Product News

ProSomnus to Design Head-to-Head Clinical Trial: OAT vs. Hypoglossal Nerve Stimulation

ProSomnus, Inc. announced plans to design a head-to-head clinical trial comparing its precision oral appliance therapy (OAT) and hypoglossal nerve stimulation (HGNS) in treating patients with severe OSA. The clinical trial plans follow updated results from the First Line Obstructive Sleep Apnea Treatment Study (FLOSAT), a prospective, independent, head-to-head, crossover […]